ArticleDrug design, development and therapy2020

Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo.

Peng Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.